English
Home > Products > 3173-56-6

China 3173-56-6 Factory

We've been also concentrating on bettering the things management and QC method in order that we could continue to keep terrific benefit inside the fiercely-competitive company for 3173-56-6,CAS NO 3173-56-6,Benzyl isocyanate, Welcome all nice buyers communicate specifics of products and ideas with us!!
3173-56-6, Hard work to keep making progress, innovation in the industry, make every effort to first-class enterprise. We try our best to build the scientific management model, to learn abundant expert knowledge, to develop advanced production equipment and production process , to create the first-call quality merchandise, reasonable price , high quality of service , quick delivery , to present you create new value .

Related Products

Hot Products

  • Pantoprazole Sodium

    Pantoprazole Sodium

    Product Name:Pantoprazole Sodium
    Molecular Formula:C16H14F2N3NaO4S
    Molecular Weight;405.35
    CAS Registry Number;138786-67-1
  • Isoflavone

    Isoflavone

    Product Name:Isoflavone
    Molecular Formula:C15H10O2
    Molecular Weight:222.24
    CAS Registry Number:574-12-9
  • 3-Aminophenol

    3-Aminophenol

    Product Name:3-Aminophenol
    Molecular Formula:C6H7NO
    Molecular Weight:109.13
    CAS Registry Number:591-27-5
  • (S)-2-Benzyl-N,N-diMethylaziridine-1-sulfonaMide

    (S)-2-Benzyl-N,N-diMethylaziridine-1-sulfonaMide

    Product Name:(S)-2-Benzyl-N,N-diMethylaziridine-1-sulfonaMide
    Molecular Formula:C11H16N2O2S
    Molecular Weight:240.32
    CAS Registry Number:902146-43-4
  • Yttrium(III) chloride

    Yttrium(III) chloride

    Product Name:Yttrium(III) chloride
    Molecular Formula:Cl3Y
    Molecular Weight:195.26
    CAS Registry Number:10361-92-9
  • Ethyl fluoroacetate

    Ethyl fluoroacetate

    Product Name:Ethyl fluoroacetate
    Molecular Formula:C4H7FO2
    Molecular Weight:106.1
    CAS Registry Number:459-72-3
  • Related Blog
  • Reviews

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • What Is Misoprostol Used For?

    Misoprostol, a derivative of prostaglandin E1, can be used in the treatment of duodenal ulcer, the prevention of anti-inflammatory induced peptic ulcer and the prevention of early pregnancy.It has the function of inhibiting the secretion of gastric acid and preventing the formation of ulcer, thus protecting the gastric mucosa...

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 3173-56-6

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept